Global Trends and Hotspots in the Field of Mitochondrial Dynamics and Hepatocellular Carcinoma: A Bibliometric Analysis from 2007 to 2023

Overview

Journal Heliyon

Specialty Social Sciences

Date 2024 Jan 31

PMID 38293381

Authors

Ruiyu Wang

Shu Huang

Ping Wang

Xiaomin Shi

Shiqi Li

Yusong Ye

Wei Zhang

Lei Shi

Xian Zhou

Xiaowei Tang

Affiliations

Soon will be listed here.

Abstract

Background: Mitochondria are dynamic organelles, and mitochondrial dynamics are important for the maintenance of mitochondrial inheritance and function. Recently, an increasing number of studies have shown that mitochondrial dynamics play an important role in the occurrence and development of hepatocellular carcinoma (HCC). However, bibliometric analyses of mitochondrial dynamics in HCC are scarce. Therefore, we conducted a bibliometric analysis to explore the current global research status and trends in mitochondrial dynamics and HCC.

Methods: Global publications on mitochondrial dynamics and HCC published between 2007 and May 2023 were retrieved from the Web of Science Core Collection (WoSCC) database. Bibliometric analysis was performed using Bibliometrix, VOSviewer, and CiteSpace to analyze the numbers, citations, countries, institutions, authors, journals, references, and keywords.

Results: A total of 518 publications were retrieved fromthe WoSCC database. China and were the most productive countries and institutions. published the most literature whereas was the author with the highest number of co-citations. was the most popular journal, whereas had the highest number of co-citations. The most frequently used keyword was "mitochondria". Further analysis of the references and keywords showed that the molecular mechanisms linking them to drug therapy targets should be the focus of future studies.

Conclusions: Research on mitochondrial dynamics in HCC has received much attention, and many studies have been published. However, research on mitochondrial dynamics and HCC has been limited by insufficient regional development imbalances and global cooperation. Nevertheless, future research on mitochondrial dynamics and HCC is promising, especially regarding the molecular mechanisms of mitochondrial fission and fusion and how to link the currently known molecular mechanisms with drug therapy targets for HCC.

References

Chen H, Ren S, Clish C, Jain M, Mootha V, McCaffery J . Titration of mitochondrial fusion rescues Mff-deficient cardiomyopathy. J Cell Biol. 2015; 211(4):795-805. PMC: 4657172. DOI: 10.1083/jcb.201507035. View

Santoni M, Rizzo A, Kucharz J, Mollica V, Rosellini M, Marchetti A . Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis. Cancer Immunol Immunother. 2023; 72(6):1365-1379. PMC: 10992808. DOI: 10.1007/s00262-022-03349-4. View

McGlynn K, Petrick J, El-Serag H . Epidemiology of Hepatocellular Carcinoma. Hepatology. 2020; 73 Suppl 1:4-13. PMC: 7577946. DOI: 10.1002/hep.31288. View

Alexander C, Votruba M, Pesch U, Thiselton D, Mayer S, Moore A . OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet. 2000; 26(2):211-5. DOI: 10.1038/79944. View

Mazumder S, De R, Debsharma S, Bindu S, Maity P, Sarkar S . Indomethacin impairs mitochondrial dynamics by activating the PKCζ-p38-DRP1 pathway and inducing apoptosis in gastric cancer and normal mucosal cells. J Biol Chem. 2019; 294(20):8238-8258. PMC: 6527165. DOI: 10.1074/jbc.RA118.004415. View

Li J, Huang Q, Long X, Guo X, Sun X, Jin X . Mitochondrial elongation-mediated glucose metabolism reprogramming is essential for tumour cell survival during energy stress. Oncogene. 2017; 36(34):4901-4912. DOI: 10.1038/onc.2017.98. View

Merz S, Hammermeister M, Altmann K, Durr M, Westermann B . Molecular machinery of mitochondrial dynamics in yeast. Biol Chem. 2007; 388(9):917-26. DOI: 10.1515/BC.2007.110. View

Zhang Z, Li T, Chen M, Xu D, Zhu Y, Hu B . MFN1-dependent alteration of mitochondrial dynamics drives hepatocellular carcinoma metastasis by glucose metabolic reprogramming. Br J Cancer. 2019; 122(2):209-220. PMC: 7052272. DOI: 10.1038/s41416-019-0658-4. View

Fazakerley D, Minard A, Krycer J, Thomas K, Stockli J, Harney D . Mitochondrial oxidative stress causes insulin resistance without disrupting oxidative phosphorylation. J Biol Chem. 2018; 293(19):7315-7328. PMC: 5950018. DOI: 10.1074/jbc.RA117.001254. View

10.

Adebayo M, Singh S, Singh A, Dasgupta S . Mitochondrial fusion and fission: The fine-tune balance for cellular homeostasis. FASEB J. 2021; 35(6):e21620. PMC: 8415099. DOI: 10.1096/fj.202100067R. View

11.

Wang W, Xie Q, Zhou X, Yao J, Zhu X, Huang P . Mitofusin-2 triggers mitochondria Ca2+ influx from the endoplasmic reticulum to induce apoptosis in hepatocellular carcinoma cells. Cancer Lett. 2014; 358(1):47-58. DOI: 10.1016/j.canlet.2014.12.025. View

12.

Meyer J, Leuthner T, Luz A . Mitochondrial fusion, fission, and mitochondrial toxicity. Toxicology. 2017; 391:42-53. PMC: 5681418. DOI: 10.1016/j.tox.2017.07.019. View

13.

Huang Q, Zhan L, Cao H, Li J, Lyu Y, Guo X . Increased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ROS-modulated coordinated regulation of the NFKB and TP53 pathways. Autophagy. 2016; 12(6):999-1014. PMC: 4922447. DOI: 10.1080/15548627.2016.1166318. View

14.

Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu M, Allen C . The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015. JAMA Oncol. 2017; 3(12):1683-1691. PMC: 5824275. DOI: 10.1001/jamaoncol.2017.3055. View

15.

Santoni M, Rizzo A, Mollica V, Matrana M, Rosellini M, Faloppi L . The impact of gender on The efficacy of immune checkpoint inhibitors in cancer patients: The MOUSEION-01 study. Crit Rev Oncol Hematol. 2022; 170:103596. DOI: 10.1016/j.critrevonc.2022.103596. View

16.

Sun X, Cao H, Zhan L, Yin C, Wang G, Liang P . Mitochondrial fission promotes cell migration by Ca /CaMKII/ERK/FAK pathway in hepatocellular carcinoma. Liver Int. 2017; 38(7):1263-1272. DOI: 10.1111/liv.13660. View

17.

Oura K, Morishita A, Tani J, Masaki T . Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review. Int J Mol Sci. 2021; 22(11). PMC: 8198390. DOI: 10.3390/ijms22115801. View

18.

Facciorusso A . The influence of diabetes in the pathogenesis and the clinical course of hepatocellular carcinoma: recent findings and new perspectives. Curr Diabetes Rev. 2013; 9(5):382-6. DOI: 10.2174/15733998113099990068. View

19.

Zhan L, Cao H, Wang G, Lyu Y, Sun X, An J . Drp1-mediated mitochondrial fission promotes cell proliferation through crosstalk of p53 and NF-κB pathways in hepatocellular carcinoma. Oncotarget. 2016; 7(40):65001-65011. PMC: 5323133. DOI: 10.18632/oncotarget.11339. View

20.

Lewis M, Lewis W . MITOCHONDRIA IN TISSUE CULTURE. Science. 1914; 39(1000):330-3. DOI: 10.1126/science.39.1000.330. View